Prognostic value of PLR in various cancers: A meta-analysis

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Zhou, Xin ^a   Du, Yiping ^a   Huang, Zebo ^a   Xu, Jun ^a   Qiu, Tianzhu ^a   Wang, Jian ^a   Wang, Tongshan ^a   Zhu, Wei ^a   Liu, Ping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL EVALUATION; COLORECTAL CANCER; DISEASE MARKER; HAZARD RATIO; HEMATOLOGICAL PARAMETERS; HUMAN; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; OVARY CANCER; OVERALL SURVIVAL; PANCREAS CANCER; PLATELET LYMPHOCYTE RATIO; PREDICTION; STOMACH CANCER; SYSTEMATIC REVIEW; BLOOD; LYMPHOCYTE COUNT; META ANALYSIS; MORTALITY; NEOPLASM; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK; THROMBOCYTE COUNT;

HUMANS; LYMPHOCYTE COUNT; NEOPLASMS; ODDS RATIO; PLATELET COUNT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84903381441     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101119     Document Type: Article

References (58)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Paul D, Kumar A, Gajbhiye A, Santra MK, Srikanth R (2013) Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. Biomed Res Int 2013: 783131.
3. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454: 436-444.
4. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545. (Pubitemid 32173595)
5. Mantovani A, Romero P, Palucka AK, Marincola FM (2008) Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 371: 771-783.
6. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081.
7. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
8. McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12: 223-226.
9. Asher V, Lee J, Innamaa A, Bali A (2011) Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol 13: 499-503.
10. Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, et al. (2012) Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 17: 216-222.
11. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6: e1000100.
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012. (Pubitemid 30214957)
13. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815-2834. (Pubitemid 28562978)
14. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
15. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
16. Smith RA, Ghaneh P, Sutton R, Raraty M, Campbell F, et al. (2008) Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg 12: 1422-1428.
17. Aliustaoglu M, Bilici A, Ustaalioglu BB, Konya V, Gucun M, et al. (2010) The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol 27: 1060-1065.
18. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI (2010) Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 200: 197-203.
19. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, et al. (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47: 2633-2641.
20. Wang DS, Ren C, Qiu MZ, Luo HY, Wang ZQ, et al. (2012) Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol 33: 749-756.
21. Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, et al. (2012) Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol 7: 587-594.
22. Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, et al. (2012) Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 29: 3092-3100.
23. Sanchez-Lara K, Turcott JG, Juarez E, Guevara P, Nunez-Valencia C, et al. (2012) Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer 64: 526-534.
24. Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E, et al. (2012) Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis 14: e701-e707.
25. Pinato DJ, Stebbing J, Ishizuka M, Khan SA, Wasan HS, et al. (2012) A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). J Hepatol 57: 1013-1020.
26. Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, et al. (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107: 988-993.
27. Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T (2012) Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol 23: 265-273.
28. Azab B, Shah N, Radbel J, Tan P, Bhatt V, et al. (2013) Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 30: 432.
29. He W, Yin C, Guo G, Jiang C, Wang F, et al. (2013) Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol 30: 439.
30. Wang D, Wu M, Feng FZ, Huang HF, Yang JX, et al. (2013) Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy. Chin Med J (Engl) 126: 1464-1468.
31. Son HJ, Park JW, Chang HJ, Kim DY, Kim BC, et al. (2013) Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. Ann Surg Oncol 20: 2908-2913.
32. Fox P, Hudson M, Brown C, Lord S, Gebski V, et al. (2013) Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer 109: 147-153.
33. Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, et al. (2013) Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109: 416-421.
34. Lee S, Oh SY, Kim SH, Lee JH, Kim MC, et al. (2013) Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer 13: 350.
35. Feng JF, Huang Y, Zhao Q, Chen QX (2013) Clinical significance of preoperative neutrophil lymphocyte ratio versus platelet lymphocyte ratio in patients with small cell carcinoma of the esophagus. ScientificWorldJournal 2013: 504365.
36. Mohamed Z, Pinato DJ, Mauri FA, Chen KW, Chang PM, et al. (2013) Inflammation as a validated prognostic determinant in carcinoma of unknown primary site. Br J Cancer.
37. Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013) Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev 14: 5237-5242.
38. Liu H, Wu Y, Wang Z, Yao Y, Chen F, et al. (2013) Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer. J Thorac Dis 5: 783-789.
39. Szkandera J, Pichler M, Absenger G, Stotz M, Arminger F, et al. (2014) The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients. Am J Surg.
40. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
41. de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6: 24-37. (Pubitemid 43053650)
42. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
43. Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, et al. (2013) Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res 19: 5456-5464.
44. Cedres S, Torrejon D, Martinez A, Martinez P, Navarro A, et al. (2012) Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol 14: 864-869.
45. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, et al. (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47: 2633-2641.
46. Bambace NM, Holmes CE (2011) The platelet contribution to cancer progression. J Thromb Haemost 9: 237-249.
47. Wiesner T, Bugl S, Mayer F, Hartmann JT, Kopp HG (2010) Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer. Clin Exp Metastasis 27: 141-149.
48. Klinger MH, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22: 913-922. (Pubitemid 35155690)
49. Alexandrakis MG, Passam FH, Moschandrea IA, Christophoridou AV, Pappa CA, et al. (2003) Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol 26: 135-140. (Pubitemid 36443554)
50. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, et al. (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9: 287-291. (Pubitemid 34298634)
51. Brown KM, Domin C, Aranha GV, Yong S, Shoup M (2005) Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas. Am J Surg 189: 278-282. (Pubitemid 40431945)
52. Sierko E, Wojtukiewicz MZ (2004) Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30: 95-108. (Pubitemid 38457304)
53. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21: 137-148. (Pubitemid 39094044)
54. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, et al. (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129. (Pubitemid 44547756)
55. Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, et al. (2011) Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 29: 1949-1955.
56. Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, et al. (2006) Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 32: 22-28. (Pubitemid 41803643)
57. Romano F, Uggeri F, Crippa S, Di Stefano G, Scotti M, et al. (2004) Immunodeficiency in different histotypes of radically operable gastrointestinal cancers. J Exp Clin Cancer Res 23: 195-200. (Pubitemid 38943549)
58. Smith RA, Bosonnet L, Ghaneh P, Sutton R, Evans J, et al. (2008) The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Surgery 143: 658-666.